Zobrazeno 1 - 10
of 180
pro vyhledávání: '"Carole D Mitnick"'
Autor:
Lawrence Oyewusi, Chengbo Zeng, KJ Seung, Stephanie Mpinda, Mikanda Kunda, Carole D Mitnick, Makelele Kanu, Meseret Tamirat, Joalane Makaka, Mabatloung Mofolo, Refiloe Maime, Llang Maama, Ninza Senyo, Bamidele Oguntoyinbo, Lwayi Mayombo, Molly F Franke
Publikováno v:
Global Health Action, Vol 17, Iss 1 (2024)
Background A low body mass index (BMI) at the start of treatment for rifampicin- or multidrug-resistant tuberculosis (MDR/RR-TB) is associated with poor treatment outcomes and may contribute to delayed sputum culture conversion, thereby prolonging th
Externí odkaz:
https://doaj.org/article/36506c03c88b452eb9791903ec8d4cc3
Autor:
Amanda M Biewer, Christine Tzelios, Karen Tintaya, Betsabe Roman, Shelley Hurwitz, Courtney M Yuen, Carole D Mitnick, Edward Nardell, Leonid Lecca, Dylan B Tierney, Ruvandhi R Nathavitharana
Publikováno v:
PLOS Global Public Health, Vol 4, Iss 2, p e0002031 (2024)
Tuberculosis (TB) transmission in healthcare facilities is common in high-incidence countries. Yet, the optimal approach for identifying inpatients who may have TB is unclear. We evaluated the diagnostic accuracy of qXR (Qure.ai, India) computer-aide
Externí odkaz:
https://doaj.org/article/ff493b7d60084111a08a3be5b40f1b18
Autor:
Carly A Rodriguez, Sara Lodi, C Robert Horsburgh, Carole D Mitnick, Mathieu Bastard, Helena Huerga, Uzma Khan, Michael Rich, Kwonjune J Seung, Sidney Atwood, Md Manzur-Ul-Alam, Nara Melikyan, Stephanie Mpinda, Zaw Myint, Yugandran Naidoo, Ofelya Petrosyan, Naseem Salahuddin, Samreen Sarfaraz, Stalz Charles Vilbrun, Kalkidan Yae, Jay Achar, Saman Ahmed, Elena Algozhina, Jude Beauchamp, Sara de Guadelupe Perea Moreno, Munara Gulanbaeva, Marika Gergedava, Cut Yulia Indah Sari, Catherine Hewison, Palwasha Khan, Molly F Franke
Publikováno v:
PLOS Global Public Health, Vol 3, Iss 4, p e0000818 (2023)
Clarity about the role of delamanid in longer regimens for multidrug-resistant TB is needed after discordant Phase IIb and Phase III randomized controlled trial results. The Phase IIb trial found that the addition of delamanid to a background regimen
Externí odkaz:
https://doaj.org/article/c6b18224da1245a6b31dc56b95bc2ad2
Autor:
Rolvix H Patterson, Chunling Lu, Carole D Mitnick, Blake C Alkire, Michelson MN Padovany, Alexis N Bowder, Eva O'Brien, Arlene M Katz
Publikováno v:
BMJ Open, Vol 12, Iss 5 (2022)
Objectives This study aimed to report household catastrophic spending on surgery and the experiences of patients and families seeking surgical care in rural Haiti.Design The study used an explanatory, sequential mixed-methods approach. We collected b
Externí odkaz:
https://doaj.org/article/bdb44f0ead6c45758b8633c769611dca
Autor:
Carly A Rodriguez, Sara Lodi, C Robert Horsburgh, Mathieu Bastard, Cathy Hewison, Helena Huerga, Munira Khan, Palwasha Y Khan, Uzma Khan, Lawrence Oyewusi, Shrivani Padayachee, Carole D Mitnick, Molly F Franke
Publikováno v:
PLoS ONE, Vol 17, Iss 11, p e0276457 (2022)
BackgroundConversion of sputum culture from positive to negative for M. tuberculosis is a key indicator of treatment response. An initial positive culture is a pre-requisite to observe conversion. Consequently, patients with a missing or negative ini
Externí odkaz:
https://doaj.org/article/546b67b03a514604b1e503e3ca58be18
Publikováno v:
PLoS ONE, Vol 17, Iss 7, p e0271102 (2022)
BackgroundTuberculosis (TB), human immunodeficiency virus (HIV), and hepatitis C virus (HCV) share a global presence and propensity to disproportionately affect marginalized populations. However, over recent decades, many fewer drugs have been brough
Externí odkaz:
https://doaj.org/article/d61f5b816e5c47afaff90daf9a9efe00
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0240297 (2020)
ObjectiveObservational tuberculosis cohort studies are often limited by a lack of long-term data characterizing survival beyond the initial treatment outcome. Though Cox proportional hazards models are often applied to these data, differential risk o
Externí odkaz:
https://doaj.org/article/6cc7d5c4e12f4385b0dd2dcf796a4715
Autor:
Patrick P J Phillips, Carole D Mitnick, James D Neaton, Payam Nahid, Christian Lienhardt, Andrew J Nunn
Publikováno v:
PLoS Medicine, Vol 16, Iss 3, p e1002767 (2019)
In a Collection Review, Patrick Phillips and colleagues discuss developments in clinical trial design for the evaluation of TB therapeutics.
Externí odkaz:
https://doaj.org/article/adfbfd6c0f87406e9bc9da0525e091ac
Publikováno v:
Bulletin of the World Health Organization, Vol 93, Iss 7, Pp 491-497 (2015)
AbstractApproximately half a million people are thought to develop multidrug-resistant tuberculosis annually. Barely 20% of these people currently receive recommended treatment and only about 10% are successfully treated. Poor access to treatment is
Externí odkaz:
https://doaj.org/article/6c7d8ed2bccf4aaaaa6038cf15caa1f5
Autor:
Grania Brigden, Bern-Thomas Nyang'wa, Philipp du Cros, Francis Varaine, Jennifer Hughes, Michael Rich, C Robert Horsburgh Jr, Carole D Mitnick, Eric Nuermberger, Helen McIlleron, Patrick PJ Phillips, Manica Balasegaram
Publikováno v:
Bulletin of the World Health Organization, Vol 92, Iss 1, Pp 68-74 (2014)
Fewer than 20% of patients with multidrug-resistant (MDR) tuberculosis are receiving treatment and there is an urgent need to scale up treatment programmes. One of the biggest barriers to scale-up is the treatment regimen, which is lengthy, complex,
Externí odkaz:
https://doaj.org/article/3a141876b7684af6b2d26b55feec2b66